Healthcare and Life Science
Want to know the secret to better business and a more fulfilled team?
In a world obsessed with strategy and tech, the real competitive edge lies in understanding people. Human behaviour training isn’t just “soft skills”—it’s the hard truth behind better leadership, faster conflict resolution, stronger communication, and thriving teams. By recognising yo...
Nuclera and Cytiva collaborate to accelerate characterization of proteins for drug development
Collaboration combines Nuclera’s eProtein Discovery System, which accelerates protein expression, purification and optimization, with Cytiva’s Biacore SPR system, which characterizes molecular interactionsCollaboration allows researchers to progress rapidly from DNA to purified and...
Cambridge’s success in fund-raising for start-ups and scale-ups benefits the whole region
A new analysis by Dealroom for Founders at the University of Cambridge showed that Cambridge startups and scaleups raised an impressive $2.3 billion in 2024, the second-best year on record and almost double 2023’s $1.2 billion that is great news for the Cambridge region as a whole. ...
Sapio Sciences appoints Gordon McCall as Chief Operating Officer to drive global operational excellence
New role underscores Sapio’s commitment to operational excellence and elevating customer delivery across global markets ...
SIRS 2025: Insights on Schizophrenia Research, From Rights Based Care to Digital Biomarkers
This year’s Schizophrenia International Research Society (SIRS) 2025 Congress in Chicago brought together leading scientists and researchers, exploring the latest advancements and ongoing challenges in understanding and addressing schizophrenia. Michael Spilka, PhD. shares his key insig...
Cambridge Cognition selected for two Phase 3 Trials combining digital cognitive and voice solutions
Cambridge Cognition (AIM: COG), the brain health software group specialising in digital products to advance clinical research and patient treatment, has been selected by a major pharmaceutical company to provide digital cognitive and voice assessments for two Phase 3 clinical trials in ...
Cambridge Cognition Secures £1million Contract for Phase 3 Autoimmune Disease Trial
Cambridge Cognition (AIM: COG), the brain health software group specialising in digital products to advance clinical research and patient treatment, has been selected by a major pharmaceutical company to provide digital cognitive assessments for a large Phase 3 autoimmune disease clinic...
Cleanroom Solutions embracing the future to elevate their large-scale facility construction provision
The Guardtech Group’s heritage turnkey brand are utilising state-of-the-art software to take their offering to another level ...
Cambridge VC investment surges to $2.3 billion as science-led innovation abounds
Cambridge startups and scaleups raised an impressive $2.3 billion in 2024, the second-best year on record and almost double 2023’s $1.2 billion. ...
Xampla’s plant protein microcapsules spotlighted in Royal Society of Chemistry journal
New peer-reviewed research in the Royal Society of Chemistry journal Sustainable Food Technology, shows Xampla’s novel plant protein microcapsules retain oil-based activities through simulated digestion, all the way to the intestinal phase. ...